In 2018, the FDA granted accelerated approval to Opdivo for SCLC based on data from the phase 1/2 CheckMate -032 trial.
Smoking is consistently seen as a risk for various cancers, and in recent years it has been connected to colorectal cancer in particular.
New mammogram-based risk measures based on brightness and texture improve breast cancer risk prediction beyond an established measure of mammographic density.
Oral contraceptives have a lasting protective effect against ovarian and endometrial cancer, according to a new study.
Among people with skin of color, ultraviolet light exposure may not be an important risk factor for melanoma.
Higher proportions of patients in the low to middle income brackets were diagnosed with localized renal cell carcinoma in states allowing Medicaid expansion.
This study examined bladder cancer that developed after radiation for any cancer potentially affecting the organ, not just prostate cancer.
Use of computed tomography and bone scans in low-risk prostate cancer cases has been in decline, but doctors continue to order these imaging modalities despite professional guidelines that do not recommend such use.
Several previously FDA-approved medicines were approved for additional uses in November 2020.
Medicaid expansion under the Affordable Care Act was linked to an increase in early-stage cancer diagnoses in the first year after expansion.
The FDA has approved therapies for the treatment of COVID-19, leukemia, Ebola, and pediatric adrenocortical insufficiency in October 2020.
Interview study identifies men’s perception and concerns related to their prostate cancer journey.
Black and Hispanic patients with cancer used telehealth less often than White patients during the COVID-19 pandemic in New York City.
Review of patient-reported outcomes identified posttreatment symptoms ranging in severity from pain to bother in women undergoing radiotherapy for breast cancer.
A posttreatment program demonstrated that nurse practitioner-led follow-up visits can be an essential component of radiation therapy.
A study in The Lancet Oncology examined the age when breast cancer screenings commonly begin, and whether researchers feel it should be sooner.
Among patients with cancer, tumor subtypes may influence varying susceptibility to SARS-CoV-2 and COVID-19 disease phenotypes.
A deep learning model based on chest radiograph images and electronic medical record data shows promise for smokers at high risk for lung cancer
A survey of MASCC clinician members identified 3 areas for further research and development to improve survivorship care plans for cancer survivors.
There is strong evidence supporting the use of radiation therapy for nonmetastatic cervical cancer.